Bowflex (BFXXQ) 10-Q 6 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'NAUTILUS, INC.	'
Entity Central Index Key	'0001078207	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	31,307,428

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$23,740	$40,979
Available-for-sale securities	17,993	0
Trade receivables, net of allowances of $42 and $53	18,265	25,336
Inventories	21,349	15,824
Prepaids and other current assets	6,238	6,927
Income taxes receivable	23	80
Deferred income tax assets	7,370	4,441
Total current assets	94,978	93,587
Property, plant and equipment, net	9,755	8,499
Goodwill	2,626	2,740
Other intangible assets, net	11,085	12,615
Long-term deferred income tax assets	18,323	25,725
Other assets	349	401
Total assets	137,116	143,567
Liabilities and Shareholders' Equity	'	'
Trade payables	21,161	37,192
Accrued liabilities	8,383	9,123
Warranty obligations, current portion	2,121	1,610
Total current liabilities	31,665	47,925
Warranty obligations, non-current	0	28
Income taxes payable, non-current	3,627	2,577
Other long-term liabilities	1,219	1,472
Total liabilities	36,511	52,002
Commitments and contingencies (Note 12)	'	'
Shareholders' equity:	'	'
Common stock - no par value, 75,000 shares authorized, 31,299 and 31,162 shares issued and outstanding	7,638	6,769
Retained earnings	92,970	84,552
Accumulated other comprehensive income (loss)	-3	244
Total shareholders' equity	100,605	91,565
Total liabilities and shareholders' equity	$137,116	$143,567

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Allowance for doubtful trade receivables	$42	$53
Common stock, par value (in dollars per share)	$0	$0
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,299,000	31,162,000
Common stock, shares outstanding	31,299,000	31,162,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$59,067	$46,256	$179,517	$141,712
Cost of sales	30,272	24,479	87,461	71,912
Gross profit	28,795	21,777	92,056	69,800
Operating expenses:	'	'	'	'
Selling and marketing	17,086	14,152	54,549	46,546
General and administrative	5,745	4,907	16,507	13,836
Research and development	1,683	1,382	5,338	3,812
Total operating expenses	24,514	20,441	76,394	64,194
Operating income	4,281	1,336	15,662	5,606
Other income (expense):	'	'	'	'
Interest income	18	4	42	5
Interest expense	-9	-10	-21	-25
Other, net	43	271	-74	292
Total other income (expense)	52	265	-53	272
Income from continuing operations before income taxes	4,333	1,601	15,609	5,878
Income tax provision (benefit)	1,669	101	5,699	-33,814
Income from continuing operations	2,664	1,500	9,910	39,692
Discontinued operations:	'	'	'	'
Loss from discontinued operations before income taxes	-241	-106	-1,075	-367
Income tax provision (benefit) from discontinued operations	-64	10	417	-81
Loss from discontinued operations	-177	-116	-1,492	-286
Net income	$2,487	$1,384	$8,418	$39,406
Earnings Per Share, Basic [Abstract]	'	'	'	'
Basic income per share from continuing operations (in dollars per share)	$0.09	$0.05	$0.32	$1.28
Basic loss per share from discontinued operation (in dollars per share)	($0.01)	$0	($0.05)	($0.01)
Basic net income per share (in dollars per share)	$0.08	$0.04	$0.27	$1.27
Earnings Per Share, Diluted [Abstract]	'	'	'	'
Diluted income per share from continuing operations (in dollars per share)	$0.08	$0.05	$0.31	$1.26
Diluted loss per share from discontinued operation (in dollars per share)	($0.01)	$0	($0.05)	($0.01)
Diluted net income per share (in dollars per share)	$0.08	$0.04	$0.27	$1.25
Shares used in per share calculations:	'	'	'	'
Basic (in shares)	31,287	31,128	31,231	31,045
Diluted (in shares)	31,655	31,488	31,641	31,419

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income	$2,487	$1,384	$8,418	$39,406
Other comprehensive income (loss):	'	'	'	'
Unrealized gain (loss) on marketable securities, net of income tax expense of $0, $0, $0 and $0	4	0	-6	0
Foreign currency translation, net of income tax expense (benefit) of $5, $(7), $6 and $14	-253	112	-241	-220
Comprehensive income	$2,238	$1,496	$8,171	$39,186

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Unrealized loss on marketable securities, tax	$0	$0	$0	$0
Foreign currency translation, net of income tax expense (benefit) of	$5	($7)	$6	$14

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Income from continuing operations	$9,910	$39,692
Loss from discontinued operations	-1,492	-286
Net income	8,418	39,406
Adjustments to reconcile net income to cash provided by operating activities:	'	'
Depreciation and amortization	2,887	2,481
Bad debt expense	38	510
Inventory lower-of-cost-or-market adjustments	305	92
Stock-based compensation expense	887	292
Loss on asset dispositions	13	9
Deferred income taxes, net of valuation allowance	4,142	-34,156
Excess tax deficiency related to stock-based awards	288	0
Changes in operating assets and liabilities:	'	'
Trade receivables, net	6,855	4,048
Inventories	-5,844	1,167
Prepaids and other current assets	763	998
Income taxes	469	-183
Trade payables	-16,079	-5,719
Accrued liabilities, including warranty obligations	196	-1,999
Net cash provided by operating activities	3,338	6,946
Cash flows from investing activities:	'	'
Purchases of available-for-sale securities	-20,973	0
Proceeds from maturities of available-for-sale securities	2,980	0
Proceeds from sale of assets of discontinued operations	0	113
Purchases of property, plant and equipment	-2,558	-2,847
Net cash used in investing activities	-20,551	-2,734
Cash flows from financing activities:	'	'
Proceeds from exercise of stock options	270	355
Excess tax deficiency related to stock-based awards	-288	0
Net cash provided by (used in) financing activities	-18	355
Effect of exchange rate changes on cash and cash equivalents	-8	-80
Increase (decrease) in cash and cash equivalents	-17,239	4,487
Cash and cash equivalents:	'	'
Beginning of period	40,979	23,207
End of period	23,740	27,694
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	21	25
Cash paid for income taxes, net	384	246
Supplemental disclosure of non-cash investing activities:	'	'
Capital expenditures incurred but not yet paid	$107	$0

General_Information

General Information	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
General Information	'
	GENERAL INFORMATION
	Basis of Consolidation and Presentation
	The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.
	The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013 (the “2013 Form 10-K”).
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2013 Form 10-K.
	In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of September 30, 2014 and December 31, 2013, our results of operations and comprehensive income for the three and nine months ended September 30, 2014 and 2013 and our cash flows for the nine months ended September 30, 2014 and 2013. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.
	Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.
	New Accounting Pronouncements
	ASU 2014-15
	In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40)". ASU 2014-15 provides guidance related to management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.
	ASU 2014-12
	In June 2014, the FASB issued ASU No. 2014-12, "Compensation - Stock Compensation (Topic 718)". ASU No. 2014-12 addresses accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. ASU 2014-12 indicates that, in such situations, the performance target should be treated as a performance condition and, accordingly, the performance target should not be reflected in estimating the grant-date fair value of the award. Instead, compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.
	ASU 2014-09
	In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP and the International Accounting Standards Board that:
	•	removes inconsistencies and weaknesses in revenue requirements;
	•	provides a more robust framework for addressing revenue issues;
	•	improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets;
	•	provides more useful information to users of financial statements through improved disclosure requirements; and
	•	simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer.
	ASU 2014-09 is effective for annual and interim periods beginning on or after December 15, 2016. While we do not expect the adoption of ASU 2014-09 to have a material effect on our business, we are still evaluating any potential impact that adoption of the ASU may have on our financial position, results of operations or cash flows.
	ASU 2014-08
	In April 2014, the FASB issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity". ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. We do not expect the adoption of ASU 2014-08 to have a material effect on our financial position, results of operations or cash flows.
	ASU 2013-11
	In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”. ASU 2013-11 amends the guidance related to the presentation of unrecognized tax benefits and allows for the reduction of a deferred tax asset for a net operating loss (“NOL”) carryforward whenever the NOL or tax credit carryforward would be available to reduce the additional taxable income or tax due if the tax position is disallowed. ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013. Since ASU 2013-11 relates only to the presentation of unrecognized tax benefits, our adoption of ASU 2013-11 in January 2014 did not have a material effect on our financial position, results of operations or cash flows.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Discontinued Operations	'
	DISCONTINUED OPERATIONS
	On September 25, 2009, in light of continuing operating losses in our Commercial business and in order to focus exclusively on managing our Direct and Retail businesses, we committed to a plan for the complete divestiture of our Commercial business, which qualified for held-for-sale accounting treatment. The Commercial business is presented as Discontinued Operations in our Condensed Consolidated Statements of Operations for all periods.
	The disposal of the Commercial business assets was completed in April 2011. We reached substantial completion of asset liquidation at December 2012. However, we continue to have legal and accounting expenses as we work with authorities on final deregistration of certain European entities and product liability expenses associated with product previously sold into the Commercial channel. There was no revenue related to the Commercial business for the year ended December 31, 2013, or the three or nine-month periods ended September 30, 2014.
	The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):
		Facilities
		Leases
	Balance, December 31, 2013	$	831
	Adjustments	—
	Payments	(192		)
	Balance, September 30, 2014	$	639
	We expect the lease obligations to be paid out through 2016.

Marketable_Securities

Marketable Securities	9 Months Ended
	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Marketable Securities	'
	MARKETABLE SECURITIES
	We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in other comprehensive income until realized. Dividend and interest income is recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.
	We periodically evaluate whether declines in fair values of our investments below their cost are "other-than-temporary." This evaluation consists of qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investment until a forecasted recovery occurs.
	For additional information, refer to Note 8, Fair Value Measurements.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	INVENTORIES
	Inventories are carried at the lower of cost or market. Cost is determined using the first-in, first-out method. We periodically review inventory for excess, obsolete and slow moving items and make provisions as necessary to properly reflect inventory value.
	Inventories consisted of the following (in thousands):
		As of
		September 30, 2014		December 31, 2013
	Finished goods	$	20,205	$	14,259
	Parts and components	1,144		1,565
	Total inventories	$	21,349	$	15,824

Property_Plant_and_Equipment

Property, Plant and Equipment	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			September 30, 2014			December 31, 2013
	Automobiles	5			$	19		$	—
	Leasehold improvements	5	to	20	2,845			2,869
	Computer software and equipment	3	to	7	28,781			35,554
	Machinery and equipment	3	to	5	6,893			5,648
	Furniture and fixtures	5			814			688
	Work in progress	N/A			335			4,281
	Total cost				39,687			49,040
	Accumulated depreciation				(29,932		)	(40,541		)
	Total property, plant and equipment, net				$	9,755		$	8,499

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Intangible Assets	'
	GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill
	All goodwill is assigned to our Direct reporting segment. The rollforward of goodwill was as follows (in thousands):
	Balance, January 1, 2013	$	2,940
	Currency exchange rate adjustment	(200		)
	Balance, December 31, 2013	2,740
	Currency exchange rate adjustment	(114		)
	Balance, September 30, 2014	$	2,626
	Other Intangible Assets
	Other intangible assets consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			September 30, 2014			December 31, 2013
	Other intangible assets:
	Indefinite-lived trademarks	N/A			$	9,052		$	9,052
	Patents	8	to	16	18,154			18,154
					27,206			27,206
	Accumulated amortization - patents				(16,121		)	(14,591		)
	Other intangible assets, net				$	11,085		$	12,615
	Amortization expense was as follows (in thousands):
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Patent amortization	$	510		$	513		$	1,530		$	1,538
	Future amortization of patents is as follows (in thousands):
	Remainder of 2014	$	510
	2015	828
	2016	430
	2017	143
	2018	65
	Thereafter	57
		$	2,033

Accrued_Liabilities

Accrued Liabilities	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Accrued Liabilities	'
	ACCRUED LIABILITIES
	Accrued liabilities consisted of the following (in thousands):
		As of
		September 30, 2014		December 31, 2013
	Payroll and related liabilities	$	4,292	$	4,244
	Other	4,091		4,879
	Total accrued liabilities	$	8,383	$	9,123

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	FAIR VALUE MEASUREMENTS
	Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:
	•	Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;
	•	Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; or observable market prices in markets with insufficient volume and/or infrequent transactions; and
	•	Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.
	Assets measured at fair value on a recurring basis were as follows (in thousands):
			September 30, 2014
			Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds		$	2,557	$	—	$	—	$	2,557
	Commercial paper		—		1,500		—		1,500
	Variable-rate demand notes		—		8,000		—		8,000
	Total Cash Equivalents		2,557		9,500		—		12,057
	Available-for-Sale Securities
	Certificates of deposit		—		5,147		—		5,147
	Corporate bonds		—		7,846		—		7,846
	Commercial paper		—		5,000		—		5,000
	Total Available-for-Sale Securities		—		17,993		—		17,993
	Total assets measured at fair value		$	2,557	$	27,493	$	—	$	30,050
	We did not have any liabilities measured at fair value on a recurring basis as of September 30, 2014 or December 31, 2013 and we did not have any assets measured as fair value on a recurring basis as of December 31, 2013.
	We recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer.  There were no transfers between levels during the three- and nine-months ended September 30, 2014.
	We did not have any changes to our valuation techniques during the nine months ended September 30, 2014.
	We classify our marketable securities as available-for-sale and, accordingly, record them at fair value based on quoted market prices. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in other comprehensive income until realized. During the first nine months of 2014 and 2013, we did not record any other-than-temporary impairments on our financial assets required to be measured at fair value on a nonrecurring basis.
	We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily Property, Plant and Equipment, Goodwill, Other Intangible Assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. We did not perform any valuations on  assets or liabilities that are valued at fair value on a nonrecurring basis during the first nine months of 2014 or during all of 2013 except for the annual Goodwill and indefinite-lived trade names impairment evaluation that was prepared effective October 1, 2013.
	The carrying value of Cash and Cash Equivalents, Trade Receivables, Prepaids and Other Current Assets, Trade Payables and Accrued Liabilities approximates their fair values due to the short-term nature of their maturities.

Product_Warranties

Product Warranties	9 Months Ended
	Sep. 30, 2014
Product Warranties Disclosures [Abstract]	'
Product Warranties	'
	PRODUCT WARRANTIES
	Our products carry limited, defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from sixty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in Cost of Sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.
	Changes in our product warranty obligations were as follows (in thousands):
		Nine months ended September 30,
		2014			2013
	Balance, beginning of period	$	1,638		$	2,492
	Accruals	1,719			951
	Adjustments	—			(186		)
	Payments	(1,236		)	(1,416		)
	Balance, end of period	$	2,121		$	1,841

Income_Per_Share

Income Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Income Per Share	'
	INCOME PER SHARE
	Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):
		Three months ended September 30,		Nine months ended September 30,
		2014	2013	2014	2013
	Shares used to calculate basic income per share	31,287	31,128	31,231	31,045
	Dilutive effect of outstanding options, performance stock units and restricted stock units	368	360	410	374
	Shares used to calculate diluted income per share	31,655	31,488	31,641	31,419
	The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share, primarily because the average market price did not exceed the exercise price. These shares may be dilutive potential common shares in the future (in thousands):
		Three months ended September 30,		Nine months ended September 30,
		2014	2013	2014	2013
	Stock options	212	298	247	303
	Performance stock units	198	84	20	17

Segment_and_Enterprisewide_Inf

Segment and Enterprise-wide Information	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment and Enterprise-wide Information	'
	SEGMENT AND ENTERPRISE-WIDE INFORMATION
	We have two reportable segments - Direct and Retail. Contribution is the measure of profit or loss, defined as Net Sales less product costs and directly attributable expenses. Directly attributable expenses include Selling and Marketing expenses, General and Administrative expenses, and Research and Development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily Accounts Receivable, Inventories and Intangible Assets. Unallocated assets primarily include shared information technology infrastructure, distribution centers, corporate headquarters, Cash and Cash Equivalents, Marketable Securities, Prepaids and Other Current Assets, Deferred Income Tax Assets, Other Assets, and capital expenditures.
	Following is summary information by reportable segment (in thousands):
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Net sales:
	Direct	$	34,498		$	25,729		$	117,589		$	93,678
	Retail	23,467			19,369			58,609			44,678
	Unallocated royalty income	1,102			1,158			3,319			3,356
	Consolidated net sales	$	59,067		$	46,256		$	179,517		$	141,712
	Contribution:
	Direct	$	4,133		$	1,316		$	18,375		$	8,533
	Retail	3,703			2,875			7,537			4,975
	Unallocated royalty income	1,102			1,158			3,319			3,356
	Consolidated contribution	$	8,938		$	5,349		$	29,231		$	16,864
	Reconciliation of consolidated contribution to income
	from continuing operations:
	Consolidated contribution	$	8,938		$	5,349		$	29,231		$	16,864
	Amounts not directly related to segments:
	Operating expenses	(4,657		)	(4,013		)	(13,569		)	(11,258		)
	Other income (expense), net	52			265			(53		)	272
	Income tax (expense) benefit	(1,669		)	(101		)	(5,699		)	33,814
	Income from continuing operations	$	2,664		$	1,500		$	9,910		$	39,692
	There was no material change in the allocation of assets by segment during the first nine months of 2014 and, accordingly, assets by segment are not presented.
	For the three and nine months ended September 30, 2014, Amazon.com accounted for 10.3% and 10.1%, respectively, of our total Net Sales. During the three months ended September 30, 2013, Amazon.com accounted for 10.6% of total Net Sales. No customer represented 10.0% or more of total Net Sales for the nine months ended September 30, 2013.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	Guarantees, Commitments and Off-Balance Sheet Arrangements
	As of September 30, 2014, we had approximately $0.6 million in standby letters of credit with certain vendors with expiration dates through April 2015.
	We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of September 30, 2014, we had approximately $35.1 million in noncancelable market-based purchase obligations, primarily for inventory purchases expected to be received within the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.
	In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.
	The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows and, therefore, no related liabilities were recorded as of September 30, 2014.
	Legal Matters
	In 2004, we were sued in the Southern District of New York by BioSig Instruments, Inc. for alleged patent infringement in connection with our incorporation of heart rate monitors into certain cardio products. No significant activity in the litigation occurred until 2008. In 2012, the United States District Court granted summary judgment to us on grounds that BioSig’s patents were invalid as a matter of law. BioSig appealed the grant of summary judgment and, in April 2013, the United States Court of Appeals for the Federal Circuit reversed the District Court’s decision on summary judgment and remanded the case to the District Court for further proceedings. On January 10, 2014, the U.S. Supreme Court granted our petition for a writ of certiorari to address the legal standard applied by the Federal Circuit in determining whether the patents may be valid under applicable law. The case was argued before the Supreme Court on April 28, 2014. By decision dated June 2, 2014, the Supreme Court unanimously reversed the Federal Circuit, holding that its standard of when a patent may be “indefinite” was incorrect and remanding to the Federal Circuit for reconsideration under the correct standard. The remand hearing in the Federal Circuit was held on October 29, 2014. We do not believe that our use of heart rate monitors utilized or purchased from third parties, and otherwise, infringe the BioSig patents.
	In August 2014, we initiated an arbitration proceeding under a 1999 license agreement pursuant to which we had licensed certain rights relating to our TreadClimber® products.  We believe that our obligation to pay royalties under the license agreement ceased in the fourth quarter of 2013. The licensor disputes this and issued a notice under the contract claiming breach of the license agreement and asserting various remedies.  We are seeking a declaratory ruling in the arbitration that we have performed all our obligations under the license agreement, and that there is no continuing obligation to pay royalties.  The licensor has asserted various counterclaims in the arbitration, including contract and intellectual property claims, and asserted various remedies, including termination of the license agreement.  The Company has replied to the counterclaim, denying the allegations and demanded remedies and asserting defenses. The arbitration is being administered by the American Arbitration Association (AAA) and is in its preliminary stages.  No arbitrator has been selected, and no schedule for the arbitration has been set.
	In addition to the matters described above, from time to time we are subject to litigation, claims and assessments that arise in the ordinary course of business, including disputes that may arise from intellectual property related matters. Management believes that any liability resulting from such additional matters will not have a material adverse effect on our financial position, results of operations or cash flows.
	We record expenses for litigation and loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. When a loss contingency is not both probable and estimable, we do not establish an accrued liability. However, if the loss (or an additional loss in excess of the accrual) is at least a reasonable possibility and material, then we disclose an estimate of the possible loss or range of loss, if such estimate can be made, or disclose that an estimate cannot be made. No amounts were accrued as of September 30, 2014 related to any outstanding litigation.
	Litigation and jury verdicts are, to some degree, inherently unpredictable, and, although we have determined that a loss is not probable in connection with any current legal proceeding at this time, it is reasonably possible that a loss may be incurred in connection with proceedings to which we are a party. Assessment of whether incurrence of a loss is probable, or a reasonable possibility, in connection with a particular proceeding, and estimation of the loss, or a range of loss, involves complex judgments and numerous uncertainties. Management is unable to estimate a range of reasonably possible losses related to litigation in its early stages, especially when the damages sought are indeterminate, or the legal and factual basis for the relevant claims have not been developed with specificity.
	We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	On November 3, 2014, our Board of Directors approved a stock repurchase program that authorizes us to repurchase up to $15 million of our outstanding common stock from time to time over the next 24 months. The repurchase program expires November 3, 2016. Share repurchases will be funded with existing cash balances and repurchased shares will be retired and returned to unissued authorized shares. To date, we have not repurchased any shares pursuant to the program.

Discontinued_Operations_Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of liabilities for exit costs related to discontinued operations	'
	The following table summarizes liabilities for exit costs related to discontinued operations, included in Accrued Liabilities and Other Long-Term Liabilities in our Condensed Consolidated Balance Sheets (in thousands):
		Facilities
		Leases
	Balance, December 31, 2013	$	831
	Adjustments	—
	Payments	(192		)
	Balance, September 30, 2014	$	639

Inventories_Tables

Inventories (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventories, Net of Valuation Allowances	'
	Inventories consisted of the following (in thousands):
		As of
		September 30, 2014		December 31, 2013
	Finished goods	$	20,205	$	14,259
	Parts and components	1,144		1,565
	Total inventories	$	21,349	$	15,824

Property_Plant_and_Equipment_T

Property, Plant, and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Schedule of Property, Plant and Equipment	'
	Property, plant and equipment consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			September 30, 2014			December 31, 2013
	Automobiles	5			$	19		$	—
	Leasehold improvements	5	to	20	2,845			2,869
	Computer software and equipment	3	to	7	28,781			35,554
	Machinery and equipment	3	to	5	6,893			5,648
	Furniture and fixtures	5			814			688
	Work in progress	N/A			335			4,281
	Total cost				39,687			49,040
	Accumulated depreciation				(29,932		)	(40,541		)
	Total property, plant and equipment, net				$	9,755		$	8,499

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill and Other Intangible Assets	'
	The rollforward of goodwill was as follows (in thousands):
	Balance, January 1, 2013	$	2,940
	Currency exchange rate adjustment	(200		)
	Balance, December 31, 2013	2,740
	Currency exchange rate adjustment	(114		)
	Balance, September 30, 2014	$	2,626
	Other Intangible Assets
	Other intangible assets consisted of the following (in thousands):
		Estimated			As of
		Useful Life
		(in years)			September 30, 2014			December 31, 2013
	Other intangible assets:
	Indefinite-lived trademarks	N/A			$	9,052		$	9,052
	Patents	8	to	16	18,154			18,154
					27,206			27,206
	Accumulated amortization - patents				(16,121		)	(14,591		)
	Other intangible assets, net				$	11,085		$	12,615
Amortization Expense	'
	Amortization expense was as follows (in thousands):
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Patent amortization	$	510		$	513		$	1,530		$	1,538
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Future amortization of patents is as follows (in thousands):
	Remainder of 2014	$	510
	2015	828
	2016	430
	2017	143
	2018	65
	Thereafter	57
		$	2,033

Accrued_Liabilities_Tables

Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Schedule of Accrued Liabilities	'
	Accrued liabilities consisted of the following (in thousands):
		As of
		September 30, 2014		December 31, 2013
	Payroll and related liabilities	$	4,292	$	4,244
	Other	4,091		4,879
	Total accrued liabilities	$	8,383	$	9,123

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Assets measured at fair value on a recurring basis	'
	Assets measured at fair value on a recurring basis were as follows (in thousands):
		September 30, 2014
		Level 1		Level 2		Level 3		Total
	Cash Equivalents
	Money market funds	$	2,557	$	—	$	—	$	2,557
	Commercial paper	—		1,500		—		1,500
	Variable-rate demand notes	—		8,000		—		8,000
	Total Cash Equivalents	2,557		9,500		—		12,057
	Available-for-Sale Securities
	Certificates of deposit	—		5,147		—		5,147
	Corporate bonds	—		7,846		—		7,846
	Commercial paper	—		5,000		—		5,000
	Total Available-for-Sale Securities	—		17,993		—		17,993
	Total assets measured at fair value	$	2,557	$	27,493	$	—	$	30,050

Product_Warranties_Tables

Product Warranties (Tables)	9 Months Ended
	Sep. 30, 2014
Product Warranties Disclosures [Abstract]	'
Schedule of Product Warranty Liability	'
	Changes in our product warranty obligations were as follows (in thousands):
		Nine months ended September 30,
		2014			2013
	Balance, beginning of period	$	1,638		$	2,492
	Accruals	1,719			951
	Adjustments	—			(186		)
	Payments	(1,236		)	(1,416		)
	Balance, end of period	$	2,121		$	1,841

Income_Per_Share_Tables

Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Weighted Average Number of Shares Outstanding Used to Compute Income Per Share	'
	The weighted average numbers of shares outstanding used to compute income per share were as follows (in thousands):
		Three months ended September 30,		Nine months ended September 30,
		2014	2013	2014	2013
	Shares used to calculate basic income per share	31,287	31,128	31,231	31,045
	Dilutive effect of outstanding options, performance stock units and restricted stock units	368	360	410	374
	Shares used to calculate diluted income per share	31,655	31,488	31,641	31,419
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
	The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share, primarily because the average market price did not exceed the exercise price. These shares may be dilutive potential common shares in the future (in thousands):
		Three months ended September 30,		Nine months ended September 30,
		2014	2013	2014	2013
	Stock options	212	298	247	303
	Performance stock units	198	84	20	17

Segment_and_Enterprisewide_Inf1

Segment and Enterprise-wide Information (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Summary Information by Reportable Segments	'
	Following is summary information by reportable segment (in thousands):
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Net sales:
	Direct	$	34,498		$	25,729		$	117,589		$	93,678
	Retail	23,467			19,369			58,609			44,678
	Unallocated royalty income	1,102			1,158			3,319			3,356
	Consolidated net sales	$	59,067		$	46,256		$	179,517		$	141,712
	Contribution:
	Direct	$	4,133		$	1,316		$	18,375		$	8,533
	Retail	3,703			2,875			7,537			4,975
	Unallocated royalty income	1,102			1,158			3,319			3,356
	Consolidated contribution	$	8,938		$	5,349		$	29,231		$	16,864
	Reconciliation of consolidated contribution to income
	from continuing operations:
	Consolidated contribution	$	8,938		$	5,349		$	29,231		$	16,864
	Amounts not directly related to segments:
	Operating expenses	(4,657		)	(4,013		)	(13,569		)	(11,258		)
	Other income (expense), net	52			265			(53		)	272
	Income tax (expense) benefit	(1,669		)	(101		)	(5,699		)	33,814
	Income from continuing operations	$	2,664		$	1,500		$	9,910		$	39,692

Discontinued_Operations_Detail

Discontinued Operations (Details) (Facilities Leases, USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Facilities Leases	'
Restructuring Reserve [Roll Forward]	'
Balance, December 31, 2013	$831
Adjustments	0
Payments	-192
Balance, September 30, 2014	$639

Inventories_Details

Inventories (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished goods	$20,205	$14,259
Parts and components	1,144	1,565
Total inventories	$21,349	$15,824

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$39,687	$49,040
Accumulated depreciation	-29,932	-40,541
Total property, plant and equipment, net	9,755	8,499
Automobiles	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	19	0
Estimated Useful Life (in years)	'5 years	'
Leasehold improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	2,845	2,869
Leasehold improvements | Minimum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'5 years	'
Leasehold improvements | Maximum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'20 years	'
Computer software and equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	28,781	35,554
Computer software and equipment | Minimum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'3 years	'
Computer software and equipment | Maximum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'7 years	'
Machinery and equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	6,893	5,648
Machinery and equipment | Minimum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'3 years	'
Machinery and equipment | Maximum	'	'
Property, Plant and Equipment [Line Items]	'	'
Estimated Useful Life (in years)	'5 years	'
Furniture and fixtures	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	814	688
Estimated Useful Life (in years)	'5 years	'
Work in Progress	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$335	$4,281

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets Goodwill Roll Forward (Details) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Goodwill [Roll Forward]	'	'
Balance	$2,740	$2,940
Currency exchange rate adjustment	-114	-200
Balance	$2,626	$2,740

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014
In Thousands, unless otherwise specified			Patents	Patents
			Minimum	Maximum
Other intangible assets:	'	'	'	'
Indefinite-lived trademarks	$9,052	$9,052	'	'
Patents	18,154	18,154	'	'
Total other intangible assets, gross	27,206	27,206	'	'
Accumulated amortization - patents	-16,121	-14,591	'	'
Other intangible assets, net	$11,085	$12,615	'	'
Estimated Useful Life (in years)	'	'	'8 years	'16 years

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets Patent amortization (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'	'
Patent amortization	$510	$513	$1,530	$1,538

Goodwill_and_Other_Intangible_5

Goodwill and Other Intangible Assets Future intangible amortization (Details) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Goodwill and Intangible Assets Disclosure [Abstract]	'
Remainder of 2014	$510
2015	828
2016	430
2017	143
2018	65
Thereafter	57
Finite-Lived Intangible Assets, Net	$2,033

Accrued_Liabilities_Details

Accrued Liabilities (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Payables and Accruals [Abstract]	'	'
Payroll and related liabilities	$4,292	$4,244
Other	4,091	4,879
Total accrued liabilities	$8,383	$9,123

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (Fair Value, Measurements, Recurring, USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	$12,057
Available for Sale Securities	17,993
Assets measured at fair value	30,050
Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	2,557
Available for Sale Securities	0
Assets measured at fair value	2,557
Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	9,500
Available for Sale Securities	17,993
Assets measured at fair value	27,493
Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Available for Sale Securities	0
Assets measured at fair value	0
Money market funds	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	2,557
Money market funds | Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	2,557
Money market funds | Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Money market funds | Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Commercial paper	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	1,500
Available for Sale Securities	5,000
Commercial paper | Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Available for Sale Securities	0
Commercial paper | Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	1,500
Available for Sale Securities	5,000
Commercial paper | Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Available for Sale Securities	0
Variable-rate demand notes	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	8,000
Variable-rate demand notes | Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Variable-rate demand notes | Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	8,000
Variable-rate demand notes | Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Cash Equivalents	0
Certificates of deposit	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	5,147
Certificates of deposit | Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	0
Certificates of deposit | Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	5,147
Certificates of deposit | Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	0
Corporate bonds	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	7,846
Corporate bonds | Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	0
Corporate bonds | Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	7,846
Corporate bonds | Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available for Sale Securities	$0

Product_Warranties_Details

Product Warranties (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Movement in Product Warranty Liability [Roll Forward]	'	'
Balance, beginning of period	$1,638	$2,492
Accruals	1,719	951
Adjustments	0	-186
Payments	-1,236	1,416
Balance, end of period	$2,121	$1,841
Minimum	'	'
Product Liability Contingency [Line Items]	'	'
Product warranty period	'60 days	'

Income_Per_Share_Details

Income Per Share (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income per share:	'	'	'	'
Shares used to calculate basic income per share	31,287	31,128	31,231	31,045
Dilutive effect of outstanding options, performance stock units and restricted stock units	368	360	410	374
Shares used to calculate diluted income per share	31,655	31,488	31,641	31,419
Stock options	'	'	'	'
Income per share:	'	'	'	'
Anti-dilutive securities excluded from computation of diluted income per share	212	298	247	303
Performance stock units	'	'	'	'
Income per share:	'	'	'	'
Anti-dilutive securities excluded from computation of diluted income per share	198	84	20	17

Segment_and_Enterprisewide_Inf2

Segment and Enterprise-wide Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
			segment
Segment Reporting Information [Line Items]	'	'	'	'
Number of reportable segments	'	'	2	'
Net sales	$59,067	$46,256	$179,517	$141,712
Contribution	8,938	5,349	29,231	16,864
Reconciliation of consolidated contribution to income (loss) from continuing operations:	'	'	'	'
Operating expenses	-24,514	-20,441	-76,394	-64,194
Income tax (expense) benefit	-1,669	-101	-5,699	33,814
Income from continuing operations	2,664	1,500	9,910	39,692
Customer Concentration Risk | Sales	'	'	'	'
Reconciliation of consolidated contribution to income (loss) from continuing operations:	'	'	'	'
Number Of major customers	'	'	'	0
Amazon.com | Customer Concentration Risk | Sales	'	'	'	'
Reconciliation of consolidated contribution to income (loss) from continuing operations:	'	'	'	'
Percentage of Net Sales	10.30%	10.60%	10.10%	'
Direct	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net sales	34,498	25,729	117,589	93,678
Contribution	4,133	1,316	18,375	8,533
Retail	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net sales	23,467	19,369	58,609	44,678
Contribution	3,703	2,875	7,537	4,975
Unallocated royalty income	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net sales	1,102	1,158	3,319	3,356
Contribution	1,102	1,158	3,319	3,356
Reconciliation of consolidated contribution to income (loss) from continuing operations:	'	'	'	'
Operating expenses	-4,657	-4,013	-13,569	-11,258
Other income (expense), net	52	265	-53	272
Income tax (expense) benefit	-1,669	-101	-5,699	33,814
Income from continuing operations	$2,664	$1,500	$9,910	$39,692

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	Sep. 30, 2014
In Millions, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'
Standby letters of credit outstanding	$0.60
Non-cancelable market-based purchase obligation	$35.10

Subsequent_Events_Details

Subsequent Events (Details) (Common Stock, Subsequent Event, USD $)	0 Months Ended
In Millions, unless otherwise specified	Nov. 03, 2014
Common Stock | Subsequent Event	'
Subsequent Event [Line Items]	'
Stock repurchase program, authorized amount	$15
Stock repurchase program, period in force	'24 months